The 2024 Responsible Business and Impact Report Shares How Gilead Sciences Is Driving Change
Gilead SciencesGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
Visit 3BL Media to see more multimedia and stories from Gilead Sciences
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Tom's Guide
an hour ago
- Tom's Guide
Pest experts reveal the reasons mosquitoes bite certain people — and you'll be surprised
Summer is here and it's the ideal time to enjoy the warm weather outdoors. And if you've spotted unsightly bites on your skin, mosquitoes are the most likely culprit. Wether you're at home or away on vacation, getting rid of mosquitoes is frustrating to say the least. At just 2 to 4 mm in size, these blood-sucking pests can bite you and leave behind an itchy or raised rash which can be irritating for days. But, if you're prone to getting mosquito bites more than your partner or family members, you might be wondering why. According to pest controllers, certain people are more enticing for mosquitoes to feast on than others — and this all depends on several factors. Luckily, we've got the experts at hand to answer all your questions, and to reveal the reasons mosquitoes will only bite certain people. Believe it or not, mosquitoes are attracted to a particular body size of a person. This is down to the amount of carbon dioxide exhaled, which attracts mosquitoes. "First, body factors do affect the menu for mosquitoes, and size plays into it," states Allan Bossel, Operations Expert at Bed Bug Exterminator. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. "Some people give off more carbon dioxide when they breathe, and that is the main chemical that attracts mosquitoes like magnets. So if you are taller or heavier, your lungs pump out more of it." Whether we're dripping in sweat in a heatwave, or have just finished a daily jog, workout or physical activity, it's probably best to jump in the shower straight away. "Sweat plays a role," states Bossel. "The lactic acid and ammonia found in sweat are two of the main attractants for mosquitoes. If you just went for a 30-minute jog and skipped a rinse, you are basically a walking mosquito lure. While daytime biting mosquitoes are increasing in range, the real pressure comes from dusk until dawn. The best way to help prevent bites is to plan ahead and be prepared with a repellent solution of your choosing that fits the occasion. If you are stationary around the table, on the porch, patio or deck, a spatial repellent like Thermacell is great to use. For those on the go, personal DEET-based sprays offer great protection." It's important to note that only female mosquitoes feed on blood and only to breed What's more, you're only likely to get bitten by female mosquitoes, as they feed on blood to breed. "Mosquitoes have evolved to really be able to zero in on their targets," adds Adam Goess, Executive Director of Innovation & Insights at Thermacell Repellents, Inc. and in-house Bug Expert. "It's important to note that only female mosquitoes feed on blood and only to breed. They are attracted to CO2 and the lactic acid on our skin. Oftentimes outdoor activities will cause us to sweat a little more or breathe a little harder, alerting mosquitoes to our presence." Another interesting reason why mosquitoes bite certain people is dependent on their blood type. "With blood type, people with Type O blood are found to be bitten more frequently than those with Type A or B" states David Price, Associate Certified Entomologist and Vice President, Strategic Growth, Mosquito Joe. "Mosquitoes can detect blood type in markers in skin secretions, although any blood type can be bitten." So, if you are a blood Type O, what are the best ways to repel buzzing mosquitoes? "Most natural solutions work by masking the odors that mosquitoes key in on (CO2, lactic acid). Solutions like vanilla extract, lavender, peppermint, eucalyptus etc., must be applied in high concentrations around every 30 minutes to see any noticeable effectiveness," advises Goess. This pure peppermint oil is paraben free, and provides a fresh scent. Versatile to use in aromatherapy, or in an oil or reed diffuser. And while the fragrance is pleasant to our senses, it is also known to be a natural mosquito and pest repellent. Luckily, there are plenty of ways to get rid of mosquitoes in your home and your yard, and you can even make your own non-toxic mosquito trap in just a few easy steps. Essential oils such as peppermint, lavender or citronella are also great, natural mosquito repellents.
Yahoo
6 hours ago
- Yahoo
Gilead Sciences, Inc. (GILD): A Bull Case Theory
We came across a bullish thesis on Gilead Sciences, Inc. on Dividend Talks's Substack. In this article, we will summarize the bulls' thesis on GILD. Gilead Sciences, Inc.'s share was trading at $110.87 as of June 30th. GILD's trailing and forward P/E were 23.29 and 14.01 respectively according to Yahoo Finance. A doctor holding a vial of medication related to antiviral treatments in a medical office. Gilead Sciences (GILD) is a leading biopharmaceutical company known for its expertise in antiviral therapies, particularly in HIV, hepatitis C, and increasingly, oncology. The company gained prominence during the COVID-19 pandemic through its antiviral drug remdesivir, which was one of the first approved treatments for the virus. Despite its scientific and commercial accomplishments, Gilead has underperformed the S&P 500 over the past decade, reflecting investor concerns around growth and pipeline execution. Currently, GILD trades at a forward P/E of 13.6x, above its five-year average of 10.5x, suggesting that some optimism may already be priced in. However, the stock is still considered to offer a 10% margin of safety at its current trading price of $107, providing potential downside protection for value-focused investors. Wall Street analysts see modest 8% upside over the next year, reflecting cautious optimism. While not a high-growth story, Gilead's stable revenue base from its HIV franchise, growing oncology pipeline, and disciplined capital allocation make it a steady compounder with defensive characteristics. The valuation, while richer than historical norms, remains reasonable in the context of the broader healthcare sector. GILD may not offer explosive upside, but it stands out as a relatively low-risk name with dependable cash flows and a track record of innovation in therapeutic areas with enduring demand. The current setup makes it a solid choice for long-term investors seeking exposure to biotech with a margin of safety and modest upside, supported by consistent execution and a diversified therapeutic portfolio. Previously we covered a on Gilead Sciences, Inc. by Disruptive Analytics in Feb 2025, which highlighted cost discipline amid revenue headwinds from policy, currency, and COVID declines. The stock has appreciated ~6.5% since as those challenges were priced in. Dividend Talks shares a similar view but emphasizes Gilead's margin of safety and steady long-term appeal. GILD isn't on our list of the 30 Most Popular Stocks Among Hedge Funds. While we acknowledge the risk and potential of GILD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Business Upturn
6 hours ago
- Business Upturn
Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
Aliso Viejo, CA, July 11, 2025 (GLOBE NEWSWIRE) — Galacxia, Inc., the developer of the Life Backup Plan app, is issuing a clarification to our July 10, 2025 press release. Annette Slyman will not be joining the team in any capacity, due to extenuating circumstances. Plans evolve. Our mission stays the course. We continue to hold Ms. Slyman in the highest regard. Galacxia remains committed to delivering innovative digital health and safety solutions that improve lives and support communities nationwide. About Life Backup Plan by Galacxia, Inc. Life Backup Plan is an end-to-end safety, emergency detection, digital health and multi-faceted care app that reduces tragedies, improves outcomes, lowers medical costs, and eases the burden on families and the healthcare system. Unlike other health and personal safety systems that require pressing a button to summon help, Life Backup Plan proactively checks on people, shares critical health data, coordinates support, and handles everything from emergency response to long-term caregiving, end-of-life planning, and daily logistics. We're delivering a comprehensive solution that bridges fragmented systems, supports value-based care, and brings modern tools into a system still largely reliant on fax machines.. Galacxia, Inc. is a SBA certified Woman-Owned Small Business and Delaware C Corporation committed to transforming personal safety, emergency response, and health access and equity. Eyes on the stars. Hands on the wheel. Heart in the mission. Press inquiries Life Backup Plan by Galacxia, Inc Sandy Eulitt [email protected] 8588480860 49 El Prado Lane, Oceanside, CA 92058
